Outcomes of adolescents using levonorgestrel implants vs oral contraceptives or other contraceptive methods.
OBJECTIVE
To compare outcomes among adolescents who use levonorgestrel implants, oral contraceptives, or other methods of birth control.


METHODS
Prospective, longitudinal study of 166 females who were followed up for 6 months. Fifty-four used implants, 64 used oral contraceptives, and 48 used condoms alone or with spermicide, or no contraceptive. Outcomes were measured by patient interview and medical chart review.


METHODS
Inner-city, hospital-based adolescent and teenaged mother and baby clinic between April 1, 1992, and May 31, 1993.


METHODS
Sexually active 12- to 18-year-old females at least 1 year postmenarche who had no contraindications to use of hormonal contraceptives.


METHODS
Sexual activity, pregnancy rates, condom use, incidence of sexually transmitted disease, patient satisfaction continuation rates, and side effects.


RESULTS
Despite similar reports of sexual activity, one subject who used the implant (2%) vs 13 subjects who used oral contraceptives (20%), and eight subjects who used other methods (17%) became pregnant (chi 2, P < .50). Condom use did not differ among groups (chi 2, P > .60). Overall, 30% of subjects contracted a new sexually transmitted disease; rates did not differ by method (chi 2, P = .92). Implant users were more likely than oral contraceptive users to continue their method (87% vs 50%; chi 2, P < .001) despite similar satisfaction scores (one-way analysis of variance, P = .52). Implant users were more likely to experience irregular menses, mood swings, acne, and hair loss (chi 2, P < .05).


CONCLUSIONS
In this population, the levonorgestrel implant is an effective method of pregnancy prevention and is associated with high satisfaction and continuation rates at 6 months. Implant users are not at greater risk than others for sexually transmitted disease. Health care providers should continue to stress the use of barrier methods to all sexually active adolescents.
Dinerman
L M
LM
Department of Pediatrics, Sinai Hospital of Baltimore, Md, USA.
Wilson
M D
MD
Duggan
A K
AK
Joffe
A
A
D000293:Adolescent; D000294:Adolescent Behavior; D017280:Condoms; D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000009:adverse effects; D004343:Drug Implants; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000008:administration & dosage*; D011247:Pregnancy; D011253:Pregnancy in Adolescence / Q000706:statistics & numerical data*; D011379:Prognosis; D011446:Prospective Studies; D012749:Sexually Transmitted Diseases / Q000453:epidemiology
D003276:Contraceptives, Oral; D004343:Drug Implants; D016912:Levonorgestrel